Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

3,425 results
  1. ... 8) _ 705 (7) 1997 (8) 7 lenophi.lia/Coagulation Disorder % (1) 209s (11) 2 (0) 6 = (0) 88 = ( ... 100) 25296 (100) , 4 Me CHILDREN | : B Hemophilia/Coagulation Disorder 4 (6) 15 = (8) 4 (3) BS (4) ...
  2. ... on BIS CHARGE OF MEN IN CONSEQUENCE OF DISEASE. 237 reference to the general return, that 234 of the ... has been found impossible to distribute either by diseases or by "T " * ** This Return has no reference Commissioned Officers and does not include the Admissions ...
  3. ... products (two percent) Persons with hemophilia or other coagulation disorders (one percent) Steady sexual contacts of persons with ... drugs, 17 percent;° @ Persons with hemophilia or other coagulation disorders, 1 percent; . © Heterosexual contacts of someones with AIDS ...
  4. ... contact, 4% to IV drug use, 2% to coagulation disorders; and 8% to blood transfusions (received before 1985). ... 12 ( 2) 21 (14) 8,117 ( 7) Hemophilia/coagulation disorder 886 ( 1) 71 (90) 80 ( 0) 15 ( 2) ...
  5. ... 8% of all cases. Persons with hemophilia or coagulation disorders who have received Factor 8 or Factor 9 ... partners of persons with AIDS 2% 27% 4% Coagulation disorders 1% >1% 1% Other transfused patients 1% 10% ...
  6. ... Bradford. Sulfanilamide therapy of bacterial infections, with special reference to diseases caused by hemolytic streptococci, pneumococci, meningo- cocci and ...
  7. NLM Digital Collections - The Health Consequences of Smoking 
    Publication: United States. Public Health Service. Office of the Surgeon General, 1974
    ... SUMMARY OF RECENT CARDIOVASCULAR FINDINGS ...------------------0 0070007 CARDIOVASCULAR DISEASE REFERENCES -.-- CARDIOVASCULAR DISEASE SUPPLEMENTAL REFERENCES --------------------77707707777 Page 10 11 ...
  8. ... Hyg., Bost., 1923-24, v, 366-370. ----- Skin diseases, with particular reference to their industrial application. Ibid., 1925-26, vii, ... B.). Spondylitis and some other forms of vertebral disease, with especial reference to diagnosis and operative treatment. Am. J. M. ...
  9. NLM Digital Collections - Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors : effectiveness ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 20, 2020
    ... Pediatrics and Pathology Pediatric Medical Director, Hemophilia and Coagulation Disorders Program Director, Special Coagulation Laboratory University of Michigan ...
  10. ... Transfusion with Blood/or Blood Products (12%) [—] Hemophilia Coagulation Disorder (5%) Wal Undetermined (4%) < __ HHS/PHS/CDC | NIDA ... Iv drug user only (16%); Remaining 10% (hemophilia/coagulation disorder (1%); heterosexual transmission (4%); oe blood/blood product ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last